Erudio Healtherudio.com
Sponsor
Taiho Oncology trials: what clinicians said in public
No HCP commentary report on a trial sponsored by Taiho Oncology yet. Erudio has found public clinician commentary on 4 clinical trials sponsored by Taiho Oncology: FOENIX-CCA2, NCT04601857, REZILIENT3 and SUNLIGHT. Each trial's page lists the podcasts, videos and posts found so far and the price of a report.
Listed by lead sponsor as registered on ClinicalTrials.gov (Taiho Oncology, Inc.). A trial led by a partner or a research group is on that sponsor's page. Only trials with public clinician commentary found are listed, not every trial the sponsor runs.
| Trial | Indication | Phase | Statements | Sources | Size | Checked | Preview |
|---|---|---|---|---|---|---|---|
| No report yetTrials with public commentary we haven't built a report for. Size is an estimate of the verified statements the commentary we've indexed so far will yield; final coverage is set when we build the report, within 24 hours of your confirmed order. You never pay more than quoted: a report delivered at a smaller size costs that size's price. Some can also be requested as a free preview. | |||||||
| FOENIX-CCA2 NCT02052778 · Taiho Oncology, Inc. DeepView → | advanced solid tumors harboring FGF/FGFR aberrations | Phase 1/Phase 2 | Deep | View | |||
| REZILIENT3 NCT05973773 · Taiho Oncology, Inc. StandardView → | untreated EGFR exon 20 insertion-mutated advanced nonsquamous NSCLC | Phase 3 | Standard | View | |||
| NCT04601857 NCT04601857 · Taiho Oncology, Inc. FocusedView → | advanced or metastatic urothelial carcinoma | Phase 2 | Focused | View | |||
| SUNLIGHT NCT04737187 · Taiho Oncology, Inc. FocusedView → | refractory metastatic colorectal cancer | Phase 3 | Focused | View | |||